Literature DB >> 31032705

Lysosomal inhibition attenuates peroxisomal gene transcription via suppression of PPARA and PPARGC1A levels.

Hayden Weng Siong Tan1,2,3, B Anjum4, Han-Ming Shen1,3, Sujoy Ghosh2, Paul M Yen2, Rohit A Sinha4.   

Abstract

Lysosomes influence dynamic cellular processes such as nutrient sensing and transcriptional regulation. To explore novel transcriptional pathways regulated by lysosomes, we performed microarray analysis followed by qPCR validation in a mouse hepatocyte cell line, AML12, treated with bafilomycin A1 (lysosomal v-type H+-translocating ATPase inhibitor). Pathway enrichment analysis revealed significant downregulation of gene sets related to peroxisomal biogenesis and peroxisomal lipid oxidation upon lysosomal inhibition. Mechanistically, pharmacological inhibition of lysosomes as well as genetic knockdown of Tfeb led to downregulation of the peroxisomal master regulator PPARA and its coactivator PPARGC1A/PGC1α. Consistently, ectopic induction of PPARA transcriptional activity rescues the effects of lysosomal inhibition on peroxisomal gene expression. Collectively, our results uncover a novel metabolic regulation of peroxisomes by lysosomes via PPARA-PPARGC1A transcriptional signalling. Abbreviations: Acox1: acyl-Coenzyme A oxidase 1, palmitoyl; Acot: acyl-CoA thioesterase; ACAA: acetyl-Coenzyme A acyltransferase; ABCD3/PMP70: ATP-binding cassette, sub-family D (ALD), member 3; BafA1: bafilomycin A1; Crot: carnitine O-octanoyltransferase; CTSB: cathepsin B; Decr2: 2-4-dienoyl-Coenzyme A reductase 2, peroxisomal; Ech1: enoyl coenzyme A hydratase 1, peroxisomal; Ehhadh: enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase; FDR: false discovery rate; Hsd17b4: hydroxysteroid (17-beta) dehydrogenase 4; NES: normalized enrichment score; NOM: nominal; Pex: peroxin; PPARA: peroxisome proliferator activated receptor alpha; PPARGC1A: peroxisome proliferator activated receptor, gamma, coactivator 1 alpha; TFEB: transcription factor EB.

Entities:  

Keywords:  NAFLD; lipid oxidation; lysosomes; peroxisomes; steatohepatitis

Mesh:

Substances:

Year:  2019        PMID: 31032705      PMCID: PMC6613898          DOI: 10.1080/15548627.2019.1609847

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  30 in total

Review 1.  Fission and proliferation of peroxisomes.

Authors:  M Schrader; N A Bonekamp; M Islinger
Journal:  Biochim Biophys Acta       Date:  2011-12-31

2.  Bafilomycin A1 inhibits the targeting of lysosomal acid hydrolases in cultured hepatocytes.

Authors:  K Oda; Y Nishimura; Y Ikehara; K Kato
Journal:  Biochem Biophys Res Commun       Date:  1991-07-15       Impact factor: 3.575

Review 3.  Peroxisome homeostasis: Mechanisms of division and selective degradation of peroxisomes in mammals.

Authors:  Masanori Honsho; Shun-ichi Yamashita; Yukio Fujiki
Journal:  Biochim Biophys Acta       Date:  2015-10-03

4.  Peroxisomal impairment in Niemann-Pick type C disease.

Authors:  S Schedin; P J Sindelar; P Pentchev; U Brunk; G Dallner
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

5.  Christian de Duve and the discovery of lysosomes and peroxisomes.

Authors:  W E Bowers
Journal:  Trends Cell Biol       Date:  1998-08       Impact factor: 20.808

6.  The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

Authors:  R B Vega; J M Huss; D P Kelly
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Alternative splicing suggests extended function of PEX26 in peroxisome biogenesis.

Authors:  Sabine Weller; Ivelisse Cajigas; James Morrell; Cassandra Obie; Gary Steel; Stephen J Gould; David Valle
Journal:  Am J Hum Genet       Date:  2005-04-27       Impact factor: 11.025

Review 8.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

9.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  Maryam Rakhshandehroo; Bianca Knoch; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2010-09-26       Impact factor: 4.964

10.  A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.

Authors:  Carmine Settembre; Roberto Zoncu; Diego L Medina; Francesco Vetrini; Serkan Erdin; SerpilUckac Erdin; Tuong Huynh; Mathieu Ferron; Gerard Karsenty; Michel C Vellard; Valeria Facchinetti; David M Sabatini; Andrea Ballabio
Journal:  EMBO J       Date:  2012-02-17       Impact factor: 11.598

View more
  9 in total

1.  Senescent Stromal Cells Promote Cancer Resistance through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles.

Authors:  Liu Han; Qilai Long; Shenjun Li; Qixia Xu; Boyi Zhang; Xuefeng Dou; Min Qian; Yannasittha Jiramongkol; Jianming Guo; Liu Cao; Y Eugene Chin; Eric W-F Lam; Jing Jiang; Yu Sun
Journal:  Cancer Res       Date:  2020-05-04       Impact factor: 12.701

Review 2.  Nuclear Receptor Coregulators in Hormone-Dependent Cancers.

Authors:  Hedieh Jafari; Shahid Hussain; Moray J Campbell
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

3.  TFEB Transcriptional Responses Reveal Negative Feedback by BHLHE40 and BHLHE41.

Authors:  Kimberly L Carey; Geraldine L C Paulus; Lingfei Wang; Dale R Balce; Jessica W Luo; Phil Bergman; Ianina C Ferder; Lingjia Kong; Nicole Renaud; Shantanu Singh; Maria Kost-Alimova; Beat Nyfeler; Kara G Lassen; Herbert W Virgin; Ramnik J Xavier
Journal:  Cell Rep       Date:  2020-11-10       Impact factor: 9.423

4.  Differentially Expressed Hepatic Genes Revealed by Transcriptomics in Pigs with Different Liver Lipid Contents.

Authors:  Wentao Lyu; Yun Xiang; Xingxin Wang; Jingshang Li; Caimei Yang; Hua Yang; Yingping Xiao
Journal:  Oxid Med Cell Longev       Date:  2022-01-28       Impact factor: 6.543

5.  Saikosaponin D inhibits autophagosome‑lysosome fusion and induces autophagy‑independent apoptosis in MDA‑MB‑231 breast cancer cells.

Authors:  Ruoqiu Fu; Lin Zhang; Yuanyuan Li; Bin Li; Yue Ming; Zhiwei Li; Haiyan Xing; Jianhong Chen
Journal:  Mol Med Rep       Date:  2020-05-18       Impact factor: 2.952

Review 6.  Hepatic Lipid Catabolism via PPARα-Lysosomal Crosstalk.

Authors:  Rohit A Sinha; Sangam Rajak; Brijesh K Singh; Paul M Yen
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

7.  Loss of ULK1 Attenuates Cholesterogenic Gene Expression in Mammalian Hepatic Cells.

Authors:  Sangam Rajak; Liliana F Iannucci; Jin Zhou; B Anjum; Nelson George; Brijesh K Singh; Sujoy Ghosh; Paul M Yen; Rohit A Sinha
Journal:  Front Cell Dev Biol       Date:  2020-09-30

Review 8.  Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease.

Authors:  Anne Fougerat; Alexandra Montagner; Nicolas Loiseau; Hervé Guillou; Walter Wahli
Journal:  Cells       Date:  2020-07-08       Impact factor: 6.600

Review 9.  PGC-1α protects from myocardial ischaemia-reperfusion injury by regulating mitonuclear communication.

Authors:  Yan-Qing Li; Yan Jiao; Ya-Nan Liu; Jia-Ying Fu; Lian-Kun Sun; Jing Su
Journal:  J Cell Mol Med       Date:  2021-01-19       Impact factor: 5.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.